These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18670644

  • 21. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ, Moini M, Giuliano J, Westra WH.
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [Abstract] [Full Text] [Related]

  • 22. Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts.
    Cao S, Durrani FA, Toth K, Rustum YM, Seshadri M.
    Oral Oncol; 2011 Jun; 47(6):459-66. PubMed ID: 21530364
    [Abstract] [Full Text] [Related]

  • 23. Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
    Nanbu T, Umemura N, Ohkoshi E, Nanbu K, Sakagami H, Shimada J.
    Oncol Rep; 2018 Jan; 39(1):367-375. PubMed ID: 29192320
    [Abstract] [Full Text] [Related]

  • 24. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.
    Kawato Y, Furuta T, Aonuma M, Yasuoka M, Yokokura T, Matsumoto K.
    Cancer Chemother Pharmacol; 1991 Jan; 28(3):192-8. PubMed ID: 1855276
    [Abstract] [Full Text] [Related]

  • 25. Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.
    Yamamoto K, Iwahana M, Kumazawa E, Kakihata K, Abe K, Hirano F, Tohgo A, Hoshiai H, Noda K.
    Oncol Rep; 2003 Jan; 10(3):593-8. PubMed ID: 12684629
    [Abstract] [Full Text] [Related]

  • 26. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
    Rischin D, Peters L, Hicks R, Hughes P, Fisher R, Hart R, Sexton M, D'Costa I, von Roemeling R.
    J Clin Oncol; 2001 Jan 15; 19(2):535-42. PubMed ID: 11208848
    [Abstract] [Full Text] [Related]

  • 27. Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
    Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA, Burow ME, Rowan BG.
    Breast Cancer Res Treat; 2009 Nov 15; 118(1):33-43. PubMed ID: 18855134
    [Abstract] [Full Text] [Related]

  • 28. Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.
    Kudoh S, Takada M, Masuda N, Nakagawa K, Itoh K, Kusunoki Y, Negoro S, Matsui K, Takifuji N, Morino H.
    Jpn J Cancer Res; 1993 Feb 15; 84(2):203-7. PubMed ID: 8385085
    [Abstract] [Full Text] [Related]

  • 29. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
    Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ.
    Clin Cancer Res; 2008 Apr 01; 14(7):2180-9. PubMed ID: 18381960
    [Abstract] [Full Text] [Related]

  • 30. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S, McGuire JJ, Rustum YM.
    Clin Cancer Res; 1999 Jul 01; 5(7):1925-34. PubMed ID: 10430100
    [Abstract] [Full Text] [Related]

  • 31. Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression.
    Yin MB, Li ZR, Cao S, Durrani FA, Azrak RG, Frank C, Rustum YM.
    Mol Pharmacol; 2004 Jul 01; 66(1):153-60. PubMed ID: 15213307
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors.
    Hicks KO, Siim BG, Jaiswal JK, Pruijn FB, Fraser AM, Patel R, Hogg A, Liyanage HD, Dorie MJ, Brown JM, Denny WA, Hay MP, Wilson WR.
    Clin Cancer Res; 2010 Oct 15; 16(20):4946-57. PubMed ID: 20732963
    [Abstract] [Full Text] [Related]

  • 33. Enhanced antitumor effect of lower-dose and longer-term CPT-11 treatment in combination with low-dose celecoxib against neuroblastoma xenografts.
    Kaneko S, Kaneko M, Fukushima T.
    Int J Clin Oncol; 2013 Feb 15; 18(1):116-25. PubMed ID: 22127347
    [Abstract] [Full Text] [Related]

  • 34. Potent therapeutic activity of irinotecan (CPT-11) and its schedule dependency in medulloblastoma xenografts in nude mice.
    Vassal G, Boland I, Santos A, Bissery MC, Terrier-Lacombe MJ, Morizet J, Sainte-Rose C, Lellouch-Tubiana A, Kalifa C, Gouyette A.
    Int J Cancer; 1997 Sep 26; 73(1):156-63. PubMed ID: 9334824
    [Abstract] [Full Text] [Related]

  • 35. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
    Cao S, Rustum YM.
    Cancer Res; 2000 Jul 15; 60(14):3717-21. PubMed ID: 10919639
    [Abstract] [Full Text] [Related]

  • 36. Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
    Siim BG, Pruijn FB, Sturman JR, Hogg A, Hay MP, Brown JM, Wilson WR.
    Cancer Res; 2004 Jan 15; 64(2):736-42. PubMed ID: 14744792
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of combined modality radiotherapy of orthotopic human squamous cell carcinomas in Nu/Nu mice using cetuximab, tirapazamine and MnSOD-plasmid liposome gene therapy.
    Epperly MW, Lai SY, Kanai AJ, Mason N, Lopresi B, Dixon T, Franicola D, Niu Y, Wilson WR, Greenberger JS.
    In Vivo; 2010 Jan 15; 24(1):1-8. PubMed ID: 20133969
    [Abstract] [Full Text] [Related]

  • 38. Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group.
    Rischin D, Peters LJ, O'Sullivan B, Giralt J, Fisher R, Yuen K, Trotti A, Bernier J, Bourhis J, Ringash J, Henke M, Kenny L.
    J Clin Oncol; 2010 Jun 20; 28(18):2989-95. PubMed ID: 20479425
    [Abstract] [Full Text] [Related]

  • 39. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.
    Prewett MC, Hooper AT, Bassi R, Ellis LM, Waksal HW, Hicklin DJ.
    Clin Cancer Res; 2002 May 20; 8(5):994-1003. PubMed ID: 12006511
    [Abstract] [Full Text] [Related]

  • 40. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.